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What Should a Support Program for People with Lung
Cancer Look Like? Differing Attitudes of Patients and
Support Group Facilitators
Bianca Devitt, MBBS,* Allison Hatton, BN,* Carl Baravelli, BSc (Hons),* Penelope Schofield, PhD,*†
Michael Jefford, PhD,*†‡ and Linda Mileshkin, MD*†
Introduction: Patients with lung cancer have higher levels of unmet
need for psychosocial support than those with other cancers. How-
ever, uptake of existing support programs by patients with lung
cancer is low. We explored this issue by seeking the views of
patients and support group facilitators.
Methods: Surveys of a convenience sample of 100 patients with
lung cancer and all support group facilitators registered with Cancer
Council Victoria (n  145) were performed. Respondents were
asked about preferred content, location, running, and potential bar-
riers to attendance of a lung cancer support program.
Results: The response rate from facilitators was 51%. Fifty-three
percent of patients reported willingness to attend a support program,
although only 12% had previously attended a group. Patients
showed a preference for any program to be held at a hospital (p 
0.01), whereas facilitators preferred a community setting (p 
0.001). Patients preferred facilitation by a health professional, rather
than a volunteer p  0.001), whereas facilitators preferred a volun-
teer. Patients preferred sessions primarily focused on cancer infor-
mation provision rather than emotional support, whereas facilitators
rated emotional support as highly as cancer information. Overall,
patients perceived fewer barriers to attendance than facilitators. Both
agreed that a group environment, discussing their cancer, parking,
and travel were barriers to attendance.
Conclusions: Disparities in the views of patients and facilitators
about the preferred location, type of facilitator, and content of a
support program may in part explain the poor uptake of existing
support programs by patients with lung cancer and should be
considered in the design of future programs.
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The majority of patients with lung cancer are diagnosedwith advanced disease, which cannot be cured with avail-
able treatments and have short survival times.1 Studies have
shown that there are significant levels of depression and need
for psychological support in patients with all stages of dis-
ease.2,3 A study assessing the concerns of patients with newly
diagnosed lung cancer found all experienced significant con-
cerns with less than half of these being adequately addressed
by the treatment team.4
A number of programs are available to provide psycho-
social support to patients with cancer, including psychologi-
cal interventions, educational programs, and peer support. A
meta-analysis of psychosocial and psychoeducational inter-
ventions found improved knowledge and lower rates of pain,
anxiety, and depression when compared with control groups.5
Small qualitative studies have shown that support groups can
improve a patient’s sense of control and confidence when
interacting with others including the medical profession as
well as providing emotional support.6,7 A systematic review
of 43 publications about peer-support programs for people
with cancer found a high level of patient satisfaction but a
lack of well-designed randomized controlled trials.8 Litera-
ture on the benefits of psychological interventions and sup-
port groups in the lung cancer population is scarce.
An extensive range of support groups and programs are
available to all patients with cancer in Victoria, Australia.
However, data suggest that patients with lung cancer do not
frequently access these services, and the support needs of
patients with lung cancer appear not adequately provided for
by available services.9 For example, in an audit of calls over
a 6-year period to the Cancer Council Helpline in Victoria,
Australia, only 2% of calls were from people with lung
cancer.10
This study aimed to determine the models of support
preferred by patients with lung cancer, as well as potential
barriers to the uptake of support programs. We also wished to
seek the views of existing support group facilitators about
these issues and compare their responses to those of patients.
METHODS
Procedure
Two paper-based, multiple-choice and short answer
questionnaires were developed by the project team, consist-
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ing of two medical oncologists, two behavioral scientists, a
lung cancer nurse coordinator, and a nurse researcher. One
questionnaire was designed for administration to patients
with lung cancer, the other, to facilitators of support groups in
Victoria, with similar questions across the two question-
naires. The patient questionnaire was pretested by 20 patients,
who were interviewed after completion by an independent
research assistant to provide feedback. The study was ap-
proved by the Human Research Ethics Committee of the
Peter MacCallum Cancer Centre.
Questionnaires
The final patient questionnaire was organized into 6
sections and consisted of 81 items: demographics, ideal
structure and content of a support group, possible barriers to
attendance, logistics of running the support group, and pre-
vious support information used. Most questions were multi-
ple choice or short answer. A three-point scale was used (“not
at all useful,” “quite useful,” “extremely useful”) to deter-
mine preferred content of a support group. Barriers to attend-
ing a lung cancer support group were rated on a three-point
scale (“not at all,” “some-what,” “very much”). The facilita-
tors’ questionnaire (74 items) was not pretested as it was very
similar. The complete questionnaires are included in online
appendices (Appendix 1, Supplemental Digital Content 1,
http://links.lww.com/JTO/A23; and Appendix 2, Supplemen-
tal Digital Content 2, http://links.lww.com/JTO/A24).
Participants
Patients
The study planned to recruit a total of 100 consecutive
patients who were identified from multidisciplinary outpa-
tient lung cancer clinics at a tertiary referral cancer center.
Eligible patients were 18 years or older, had adequate English
to complete the questionnaire, a current or previous diagnosis
of lung cancer or mesothelioma, and were attending an
outpatient clinic appointment subsequent to an initial consul-
tation. Patients who had cognitive impairment or an Eastern
Co-operative Oncology Group performance status greater
than 2 were excluded.
A nurse researcher discussed the study with patients
and written informed consent was obtained. Participants com-
pleted the questionnaire during their outpatient attendance or
were supplied with a reply paid envelope to return the
completed questionnaire.
Support Group Facilitators
All support groups facilitators affiliated with Cancer
Council Victoria were invited to participate in the facilitator
questionnaire, which was mailed with a covering letter. Fa-
cilitators were eligible if they were involved in co-ordination
or delivery of a Cancer Council Victoria affiliated cancer
support program within the last 12 months. A decision was
made survey all facilitators, even if they ran an unrelated
disease-specific support group (e.g., breast) as we were aware
that there were likely to be few lung groups, but felt that the
views of experienced facilitators, who may have been in-
volved with several groups over time would still be informa-
tive. Two further questionnaire mail outs were sent and a
telephone call made to initial nonresponders.
Statistical Analysis
Statistical Package SPSS15 (SPSS Inc., Chicago, IL)
was used to analyze the data. Frequency counts and percent-
ages were calculated for patient characteristics and 2 tests
were used to assess the difference in responses between
patients and facilitators. A p value of 0.05 was considered
significant.
RESULTS
Two hundred sixty-three potential patient participants
were identified from outpatient clinics during a 12-month
period. Ninety-one patients were ineligible to participate (61:
inadequate English, 16: enrolled on another clinical trial, 10:
cognitive impairment, and 4: too unwell). One hundred thirty-
eight patients consented to participate and 34 declined. Thi-
rty-seven patients consented and elected to take the question-
naire home after seeing the doctor but did not return it,
possibly because it was quite lengthy or their consultation had
been distressing. One hundred one of 172 eligible participants
(response rate  59%) returned completed questionnaires.
All 145 cancer support group facilitators registered
with Cancer Council Victoria were invited to participate in
the questionnaire survey. These groups comprised 65 general
groups and 80 disease-specific groups, most of which were
for breast cancer. A breakdown of the disease types for the
disease-specific groups is given in Figure 1. Seventy-four
questionnaires were returned giving a response rate of 51%.
Patient Demographics
Patient demographics are shown in Table 1.
Facilitator and Support Group Demographics
The majority (78%) of facilitators responding to the
questionnaire were women. Their median age was 57 years
(range, 35–79). Thirty-one (42%) facilitators were heath
professionals, 26 (35%) cancer survivors, and 17 (23%) were
volunteers. Thirty-eight (51%) respondents had completed
facilitator training and 35 (49%) ran a tumor-specific support
meeting with 2 of the 35 groups being asbestos related, but
none being specifically for other types of patients with lung
cancer. Nonrespondents appeared similar with 80% being
women and 63% running a disease-specific support group.
FIGURE 1. Disease-specific support groups registered with
the Cancer Council Victoria.
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The majority of the groups met monthly (78%) and
contained a median number of 15 participants per session
(range, 3–50). Sixty-four percent of meetings were held in a
community setting and 89% included carers and friends. Only
25 facilitators (34%) had previously had a patient with lung
cancer attend their support group. These facilitators could
recall a median of 3 such patients (range, 1–8). Seventeen
facilitators (23%) could recall a friend or carer of a patient
with lung cancer attending their group.
Prior Use and Utility of Cancer Information
Resources
Patients were asked what additional cancer information
resources they had previously used: printed pamphlets or
booklets for people with cancer, phone support, face-to-face
support, or internet sites. Seventy-eight percent of patients
indicated that they had used printed information. Twenty-
nine percent had used the internet for cancer information.
Both sources were considered to be useful by 92% of
patients. Eighteen percent of patients had used some form of
general telephone support. Only a small proportion of all
patients (12%) had accessed face-to-face support groups,
with 67% of those who had reporting them as useful.
Preferred Content of Support Program
Facilitators and patients were asked about the ideal
content of a support program. There was a significant differ-
ence between some of the content that was deemed “quite
useful” or “extremely useful” by patients when compared
with facilitators (Table 2). Most of patients (n  94, 93%)
wished to receive “information about lung cancer treatments”
and “information about side effects of treatment” (n  97,
96%). Facilitators rated this information less highly with 56
(76%) considering treatment information useful and 60 (81%)
indicating that information about side effects would be useful
(both p 0.002 compared with patients). Information regard-
ing lifestyle factors such as diet, exercise, and breathing
exercises were considered equally useful by both groups.
There was a significant difference in desire for social
and emotional support. Sixty-six percent of patients believed
“social and emotional support” for themselves or their fam-
ilies (59%) was a useful part of a support program, whereas
the facilitators rated this as highly (84 and 78%, respectively)
as cancer information and lifestyle factors (both p  0.05).
Similarly, 47 (64%) of facilitators thought “spiritual support”
was useful compared with 36 (36%) of patients (p  0.001).
Sixty-seven patients (66%) would find “meeting and talking
with people who have lung cancer” useful, whereas 60 (81%)
of facilitators thought this useful (p  0.04).
Preferred Support Group Format and Barriers to
Participation
When patients were asked whether they would attend a
support program for people with lung cancer, 54 (53%)
indicated that they would be “likely” or “very likely” to
participate, 18 (18%) were unsure and 27 (27%) would be
“unlikely” or “very unlikely” to attend (2  no response).
Patients showed a significant preference for the ses-
sions to be conducted by a health professional (83%) rather
than a volunteer with cancer experience (64%), and to be held
in a hospital (66%) rather than a community setting (41%;
Table 2). In contrast, facilitators preferred the support group
to be held in a community location (70%) rather than a
hospital (46%) and showed a slight preference for volunteer
facilitators with cancer experience (61%) over health profes-
sionals (54%). Patients also demonstrated a preference for the
support groups to include only patients with lung cancer
(66%), whereas facilitators did not have a clear preference
regarding group composition. Both groups preferred “one-on-
one” support or a small group format.
Facilitators identified more barriers to participation in
support groups than patients with lung cancer (Table 3).
Forty-nine facilitators (68%) believed that people with lung
cancer would not want to attend any type of support program
TABLE 1. Patient Demographics
No. of Patients (%)
Median age (yr) 68 (range, 32–85)
Male 59 (58)
Married/de facto 63 (62)
ECOG 0–1 89 (88)
ECOG 2 12 (12)
Education
No education 1 (1)
Primary 20 (20)
Secondary or equivalent 55 (54)
Tertiary 16 (16)
Others 8 (8)
No response 1 (1)
Employment
Working 32 (32)
Retired 58 (57)
Sick leave/unemployed 5 (5)
Others 5 (5)
No response 1 (1)
Location
Urban (lived within the city) 68 (67)
Rural 33 (33)
Current smoker 12 (12)
Disease type
Non-small cell 75 (74)
Small cell 16 (16)
Mesothelioma 5 (5)
Presumed, no biopsy 5 (5)
Disease stage
Local disease 57 (56)
Metastatic 42 (42)
Unknown (not staged) 2 (2)
Treatment
On active treatment 39 (39)
Observation 62 (61)
Time since last treatment (mo)
Median 10
Range 0–97
ECOG, Eastern Co-operative Oncology Group.
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due to “feeling too unwell,” whereas only 30 (30%) of
patients identified this as a possible barrier (p  0.001).
Similarly, “work commitments,” “not wanting to travel,” and
“feeling ashamed about lung cancer” were considered greater
barriers to participation by facilitators than patients (all p 
0.002).
DISCUSSION
Our results show that there are significant differences
between patients with lung cancer and cancer support group
facilitators regarding preferences for support services. Over-
all, patients prefer one-on-one or small group support ses-
sions, containing participants with lung cancer only, con-
ducted in a hospital environment. They appear to value
information about treatment and self-care over psychological
support. Ideally, sessions would involve, or be conducted by,
a health care professional. Facilitators however, prefer sup-
port groups to be held in a community setting and focus
heavily on psychological support. These findings are consis-
tent with the results from a questionnaire study performed by
TABLE 2. Preferred Content and Format of Support Program
No. of Patients (%)
“Useful of Very Useful”
No. of Facilitators (%)
“Useful or Very Useful” p
Content
Patients and facilitators: “How useful would the following be in a lung cancer
support program?”
Information about lung cancer
Information about what lung cancer is 89 (88) 59 (78) 0.143
Information about available lung cancer treatments 94 (93) 56 (76) 0.002
Information about side effects of treatment 97 (96) 60 (81) 0.002
Information about being involved in making treatment decisions 90 (89) 58 (78) 0.059
Information about palliative care 79 (78) 62 (84) 0.44
Information about lifestyle factors
Information about diet 84 (83) 60 (81) 0.841
Information about exercise 89 (88) 58 (78) 0.097
Information about breathing exercises 84 (83) 53 (72) 0.057
Information about complementary therapies 75 (74) 49 (66) 0.312
Social and emotional support
Financial advice and guidance 57 (56) 53 (72) 0.057
Social and emotional support for self 67 (66) 62 (84) 0.014
Social and emotional support for family 60 (59) 59 (80) 0.005
Spiritual/religious support 36 (36) 47 (64) 0.001
Communication
Meeting with talking with people who have lung cancer 67 (66) 60 (81) 0.039
Meeting and talking to health professionals e.g., a nurse, dietician 90 (89) 62 (84) 0.367
Format
Patient: “If you were to participate in a support group for people with lung cancer,
would you like?”
Facilitator: “Do you think the following are appropriate features of a support
program for people with lung cancer?”
Location of support group
To meet face-to-face—held at the hospital 67 (66) 34 (46) 0.01
To meet face-to-face—at the local community building (e.g. council room,
church hall)
41 (41) 52 (70) 0.001
Group size
To meet one-on-one (e.g., talking to a cancer survivor) 70 (69) 53 (72) 0.86
To meet with a small group (e.g., 5) 61 (60) 46 (62) 0.87
To meet with a large group (e.g., 10 or more) 41 (41) 38 (51) 0.17
Facilitator background
A health professional (e.g., a nurse or social worker) to run the support program 84 (83) 40 (54) 0.001
A volunteer with lung cancer to run the program 66 (65) 48 (65) 1.0
A volunteer who has had personal experience of cancer to run the program 65 (64) 45 (61) 0.64
Participants
The program to include people with all types of cancer 53 (52) 31 (42) 0.17
The program to include people with lung cancer only 67 (66) 36 (49) 0.02
The program to include people with all types of cancer and their family/caregivers 45 (45) 33 (45) 1.0
The program to include people with lung cancer and their family/caregivers only 57 (56) 35 (47) 0.28
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Butow et al.11 who surveyed patients with cancer and carers
attending a support group about their preferences for content
and organization of the group. Attendees rated most highly
keeping abreast of current medical research, cancer treat-
ments, and their side effects. They also valued the supportive
aspects of group attendance in terms of “knowing that I am
not alone.” They preferred the meetings to be held in a
hospital rather than community environment, a preference
which was more pronounced in men with prostate cancer. In
keeping with our results, this study also showed patients
preferred that support groups contain only those people with
the same malignancy. There was a strong preference (97%)
however, for the groups to contain people with both poor and
better prognoses.
There are some limitations to our results; this includes
possible selection bias with only a subset of consecutive
patients being willing to complete the survey and the use of
a convenience sample with very sick patients excluded. In
addition, our patients came from a tertiary referral center with
access to a full range of allied health services and a dedicated
lung cancer nurse coordinator.12 The needs of patients with
lung cancer treated in community practices could well be
different. Although nonresponders may not have had any
needs for additional support, alternatively they could have
more but have not agreed to participate due to other issues
such as low literacy or high levels of anxiety and depres-
sion.13,14 In contrast with other literature, most patients in our
study did not perceive smoking-related stigma as a barrier to
obtaining support despite being ex-smokers.15
Because of the format of the study, patients with
limited English were excluded. This group of patients have
been shown to be at increased risk of depression and anxiety
and report less satisfaction with the provision of treatment
information and psychosocial care when compared with En-
glish-speaking patients.16,17 Given these issues, further eval-
uation of their needs is warranted. In addition, further assess-
ment of the needs of carers, who we did not include in our
study, is also vital.
Utilization of face-to-face support programs was low in
our cohort and is similar to other studies with reported
attendance at cancer-specific support groups ranging from 8
to 11%.18,19 As more than one half of those sampled were
interested in attending a support program, there is clearly an
unmet need for support for patients with lung cancer. The
poor attendance of support programs could also be due to a
lack of knowledge about their existence.20 Bui et al.21 found
that recommendation from medical staff to attend a support
program was an independent predictor of interest to attend.
Few, if any support groups, are in place to specifically
cater for the needs of patients with lung cancer despite the
prevalence of lung cancer in our community. We believe our
study is the first to examine lung cancer patients’ specific
preferences and shows there is significant discrepancy be-
tween the support currently offered and this group’s needs.
Education of facilitators about patients’ views is important.
Although facilitators and health professionals may perceive
that many patients have a need for emotional support, patients
primarily express a desire for more information. It is also
TABLE 3. Barriers to Participation in a Support Group
No. of Patients (%)
Answering “Somewhat” or
“Very Much” (n  101)
No. of Facilitators (%)
Answering “Somewhat” or
“Very Much” (n  72) p
Patient factors
I don’t want to participate in group situations 42 (42) 35 (49) 0.44
I feel too unwell 30 (30) 49 (68) 0.001
I feel ashamed about my lung cancer 10 (10) 21 (29) 0.002
I don’t want to talk about my lung cancer 37 (37) 32 (44) 0.35
Language difficulties 1 (1) 26 (36) 0.001
I have too many other health-related appointments to go to 18 (18) 39 (54) 0.001
I don’t want to be pressured to quit smoking 8 (8) 38 (53) 0.001
I feel I might be judged for continuing to smoke 9 (9) 39 (54) 0.001
I am worried I might not be able to smoke 2 (2) 28 (39) 0.001
I don’t have a friend or family member to go with 12 (12) 33 (46) 0.001
I don’t want to see people sicker than themselves 28 (28) 39 (54) 0.001
Physical factors
Work commitments 9 (9) 37 (51) 0.001
I have difficulty with transport and parking 38 (38) 39 (54) 0.04
I don’t want to travel 37 (37) 45 (63) 0.001
Child care difficulties 1 (1) 28 (39) 0.001
I have to go to the hospital or medical centre to participate 30 (30) 27 (38) 0.33
Support group factors
The program being run by a nurse 16 (16) 19 (26) 0.12
The program being run by a psychologist 24 (24) 26 (36) 0.09
The program being run by a social worker 25 (25) 22 (31) 0.49
The program being run by a volunteer who has lung cancer 29 (29) 14 (19) 0.22
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possible that patients are more comfortable requesting infor-
mation rather than support despite needs for both. A previous
study found that men with cancer emphasized information
seeking over support when compared with women, but had
higher levels of fear and anxiety.22
It is likely that as the complexity of cancer management
has increased, it is no longer possible to run support and
information groups in a “one-size-fits-all” model. This may
increase the already significant resource limitations including
the provision of services to rural settings. Through the use of
modern information technology such as teleconferencing, the
internet and the development of DVDs some of these issues
may be overcome.23,24
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